Overcoming Challenges Faced with Traditional Flow Cytometry in Cell Therapy Manufacturing with the Accellix Automated Flow Cytometer
12 April 2023
Automation & Digitisation
Thursday, May 4, 2023 | 08:00 [EDT] | 11:00 [PDT] | 16:00 [BST]
Hear from one of the fastest moving cell therapy companies about how they automated their cell therapy QC platform by incorporating Accellix, overcoming manual, laborious sample preparation and analysis with traditional flow cytometry and expediting drug release.
WHAT TO EXPECT
Part 1: The speaker will be interviewed and asked to address key challenges associated with traditional flow cytometry in cell therapy manufacturing
- Current challenges in traditional flow cytometry for QC release testing
- Benefits of Accellix: an automated flow cytometry platform
- Accellix vs traditional flow cytometry – method comparison (data)
- Manual data analysis vs autoclassification with release QC assay (data)
- Cellpoint/Galapagos automated and rapid workflow for manufacturing
Part 2: The speaker answers audience questions with an interactive Q&A.
This content is brought to you in partnership with Accellix.
More like this
Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer
Eureka Therapeutics has received a $10.6 million grant from the California Institute for Regenerative Medicine (CIRM) to support its ongoing ARYA-2 Phase I study of ET140203 for the treatment of refractory/relapsed liver cancer for pediatric patients.
8 June 2023
Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities
UK-based independent innovation and technology organization Cell and Gene Therapy Catapult (CGT Catapult), has officially opened new laboratories and offices in Edinburgh, Scotland, UK, BioQuarter – enhancing Edinburgh’s role as a hub for cell therapies.
7 June 2023
BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies
BioCentriq launched their new LEAP™ Advanced Therapy Platform at the 29th International Society for Cell & Gene Therapy (ISCT) annual event with proven assets and expertise to help early-stage biotech companies effectively deliver to patients without compromising quality.
5 June 2023